cagrilintide tirzepatide combination trial CagriSema vs Tirzepatide: Weight Loss Results in REDEFINE 4 | Paramesh Shamanna posted on the topic CagriSema vs tirzepatide: which next-generation

Description

an investigational combination therapy being developed by Novo Nordisk that merges two powerful agents: (1) a long-acting amylin analog with a sequence to make it a calcitonin receptor agonist (2) a blockbuster GLP-1 receptor agonist ?via complementary hormonal pathways: mimics the natural hormone amylin, which is co-secreted with insulin

Discover how TRT Nation's compounded tirzepatide with B12 supports safe, sustainable weight loss

2.4 mg recently FDA-approved for MASH reduction

But a humble prebiotic may nudge the same hormone the blockbuster drugs target - here's what the science actually says.

Semaglutide is a GLP-1 receptor analogwhile tirzepatide is a dual agonist that targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors